Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News BG Medicine Inc BGMD

Metals & Mining Technology Industrial Metals & Minerals Scientific & Technical Instruments

BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in... see more

Add To Watchlist

Recent & Breaking News (GREY:BGMD)

Cardiac Biomarker ST2 Helps Assess Heart Failure Risk And Identify Heart Failure Patients Likely To Benefit From Exercise

Business Wire October 10, 2013

Cardiac Biomarker ST2 Proves Far Superior To Galectin-3 In A Head-to-Head Study

Business Wire September 30, 2013

BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test

Globe Newswire September 30, 2013

BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients

Globe Newswire September 23, 2013

BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the Heart Failure Society of America

Globe Newswire September 19, 2013

Flagship VentureLabs Launches Midori Renewables

PR Newswire September 4, 2013

BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference

Globe Newswire September 4, 2013

The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014

PR Newswire August 28, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on BGMD, CORT, ELX and TTEK

Accesswire August 12, 2013

BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook

Globe Newswire August 8, 2013

BG Medicine to Announce Second Quarter 2013 Financial Results and Host Conference Call on Thursday, August 8, 2013

Globe Newswire August 1, 2013

Flagship Ventures Kicks-off its VentureLabs(TM) Entrepreneurial Fellowship Program

PR Newswire June 20, 2013

BG Medicine Welcomes Inclusion of Galectin-3 as Biomarker of Myocardial Fibrosis in 2013 ACCF/AHA Guideline for Management of Heart Failure

Globe Newswire June 12, 2013

Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals

PR Newswire May 31, 2013

Free Research Reports on BGMD, CPST, ENOC and STSI Issued by the Paragon Report

Marketwired May 29, 2013

BG Medicine Announces Late-Breaker Oral Presentation of New Data on the BGM Galectin-3(R) Test in Heart Failure

Globe Newswire May 28, 2013

Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures

PR Newswire May 22, 2013

BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Globe Newswire May 10, 2013

BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer

Globe Newswire May 9, 2013

BG Medicine Reports 2013 First Quarter Financial Results

Globe Newswire May 9, 2013